Latest Patents News

Critical Resources has achieved a key milestone by depositing a complete solid-state battery cathode layer in one dry, solvent-free step, potentially simplifying and cutting costs in battery production for high-demand sectors.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.

Syntara Limited has completed a $0.84 million Share Purchase Plan, boosting its total capital raise to $8.84 million to fund multiple clinical trials and patent development through to Q3 2027.

IperionX’s Titan Definitive Feasibility Study outlines a shovel-ready Tennessee project targeting heavy rare earths, titanium, zirconium, and hafnium with robust economics and strategic US supply chain implications.

dorsaVi has secured exclusive rights to two key robotics patents from NTU Singapore, filling critical gaps in safety control and data acquisition to expand into collaborative robotics and exoskeleton markets.

Sentinel Metals has kicked off its first diamond drilling campaign at the Columbia Gold-Silver Project in Montana, marking a major regulatory milestone and deploying a low-emission rig to test high-priority targets.

Nimy Resources has identified a 16km gold anomaly corridor at its Mons Project in Western Australia, including the new Corporate James prospect, and is preparing a drill program to test these promising targets.

VEEM Limited has finished its factory extension and installed new machinery, setting the stage for a stronger second half of FY26 and anticipated growth in FY27 driven by defence contracts and marine propulsion innovations.

Racura Oncology has secured $31.2 million in funding to advance its lead cancer drug RC220, including a strategic $1 million private placement to a specialist healthcare investor.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Entropy Neurodynamics has successfully dosed all six participants in the first cohort of its Phase 2 trial for TRP-8803, an intravenous psilocin therapy targeting Binge Eating Disorder. The study demonstrated controlled psychedelic responses, setting the stage for a Data and Safety Monitoring Board review and topline results expected in July 2026.

Independent U.S. Army and WMTR testing confirms IperionX's Ti-6Al-4V fasteners outperform high-strength Grade 8 steel in torque-to-yield and tensile strength, underpinning a secure domestic titanium supply chain.